CHRISTOPHER HENNEY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2023-11-14 Dr. Christopher Henney ... 61,415 shares beneficially owned.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04